冠動脈ステントの世界市場レポート 2025年

冠動脈ステント市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.3％で165億米ドルに成長します。予測期間の成長は、心血管疾患の罹患率の増加、高齢化、心血管の健康に対する意識の高まり、政府の支援プログラムや資金援助、生活習慣病の罹患率の増加などに起因しています。予測期間の主な動向には、ステント技術の革新、イメージング技術の革新、戦略的提携とパートナーシップ、ステント材料の革新、デジタルヘルスとの技術統合などがあります。

心血管疾患（CVDs）の有病率の増加が冠動脈ステント市場の拡大を促進すると予想されます。CVDには、冠動脈疾患、心不全、脳卒中、高血圧など、さまざまな心臓や血管の障害が含まれます。心血管疾患の増加は、人口の高齢化、肥満、糖尿病、座りがちなライフスタイル、食生活の乱れ、ストレスなどの危険因子の増加といった要因に起因しています。冠動脈ステントは、冠動脈の狭窄や閉塞を開き、心臓への血流を改善し、心臓発作のリスクを軽減するため、CVDの治療において極めて重要です。例えば、2022年8月に米国心臓病学会が発表した報告書では、2025年から2060年までの米国における心血管危険因子の大幅な増加が予測されています。糖尿病が39.3％増の5,500万人、脂質異常症が27.6％増の1億2,600万人、高血圧が25.1％増の1億6,200万人、肥満が18.3％増の1億2,600万人になると予測しました。最も顕著な増加は、脳卒中（33.8％増の1,500万人）と心不全（33.4％増の1,300万人）で、虚血性心疾患と心臓発作も大幅な増加を示しています。このようなCVDの有病率の上昇が、冠動脈ステントの需要を牽引しています。

冠動脈ステント市場の各社は、従来のベアメタルステントと比較して再手術の必要性を最小限に抑えるため、薬剤溶出ステントなどの先進製品の開発に注力しています。薬剤溶出ステントは、動脈が再び狭くなるのを防ぐ薬剤を徐々に放出する薬剤でコーティングされた特殊な装置です。例えば、2024年5月、米国のヘルスケア企業であるアボット社は、インドでXIENCE Sierraエベロリムス溶出冠動脈ステントシステムを発表しました。このステントは、強化されたデザイン、新しいデリバリーシステム、複雑な症例に合わせた独自のサイズオプションを特徴としています。このステントは、他のXIENCEステントと同様、動脈の再閉塞のリスクを低減する特殊なコーティングが施されており、12万人以上の患者を対象とした120以上の臨床試験に裏付けられた高い安全性実績を誇っています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界冠動脈ステント PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の冠動脈ステント市場：成長率分析
• 世界の冠動脈ステント市場の実績：規模と成長, 2019-2024
• 世界の冠動脈ステント市場の予測：規模と成長, 2024-2029, 2034F
• 世界冠動脈ステント総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の冠動脈ステント市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• デュアルセラピーステント
• 放射性ステント
• 血栓除去ステント
• カバー付きステント
• 生体吸収性ステント
• 生分解性ステント
• ハイブリッドステント
• 薬剤溶出ステント
• ベアメタルステント
• 世界の冠動脈ステント市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• レーザー切断
• 3Dプリントステント
• 微細加工
• ナノテクノロジーベースのステント
• 電解研磨
• その他のテクノロジー
• 世界の冠動脈ステント市場：原材料別、実績と予測, 2019-2024, 2024-2029F, 2034F
• コバルトクロム
• ステンレス鋼
• プラチナクロム
• ニッケルチタン
• ポリマー
• 世界の冠動脈ステント市場：展開別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 自己拡張型ステント
• バルーン拡張型ステント
• 世界の冠動脈ステント市場最終用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院および外来手術センター
• 専門クリニック
• その他の用途
• 世界の冠動脈ステント市場デュアルセラピーステントの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• シロリムス溶出デュアルセラピーステント
• パクリタキセル溶出デュアルセラピーステント
• エベロリムス溶出デュアルセラピーステント
• 世界の冠動脈ステント市場放射性ステントの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ベータ線ステント
• ガンマ線ステント
• その他の放射線ステント
• 世界の冠動脈ステント市場血栓除去ステントの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 手動血栓除去ステント
• 機械的血栓除去ステント
• 流体力学的血栓除去ステント
• 世界の冠動脈ステント市場カバー付きステントの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• PTFE被覆ステント
• ePTFEカバーステント
• ポリウレタン被覆ステント
• その他のカバー付きステント
• 世界の冠動脈ステント市場生体吸収性ステントの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ポリマーベースの生体吸収性ステント
• 金属ベースの生体吸収性ステント
• セラミックベースの生体吸収性ステント
• 世界の冠動脈ステント市場生分解性ステントの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ポリマー生分解性ステント
• マグネシウムベースの生分解性ステント
• その他の生分解性ステント
• 世界の冠動脈ステント市場ハイブリッドステントの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ハイブリッド薬剤溶出ステント
• ハイブリッド生分解性ステントまたは金属ステント
• その他のハイブリッドステント
• 世界の冠動脈ステント市場薬剤溶出ステントの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• シロリムス溶出ステント
• パクリタキセル溶出ステント
• エベロリムス溶出ステント
• ゾタロリムス溶出ステント
• その他の薬剤溶出ステント
• 世界の冠動脈ステント市場ベアメタルステントの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ステンレス鋼ベアメタルステント
• コバルトクロムベアメタルステント
• その他のベアメタルステント

第7章 地域別・国別分析

• 世界の冠動脈ステント市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の冠動脈ステント市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 冠動脈ステント市場：競合情勢
• 冠動脈ステント市場：企業プロファイル
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
  • Biosensors International Group Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
  • B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Terumo Corporation
• W. L. Gore & Associates Inc.
• Cook Medical Inc.
• BIOTRONIK SE & Co. KG
• Lepu Medical Technology（Beijing）Co. Ltd.
• Meril Life Sciences Pvt. Ltd.
• MicroPort Scientific Corporation
• OrbusNeich
• Asahi Intecc Co. Ltd.
• Sahajanand Medical Technologies Limited
• Translumina GmbH
• Stentys S.A.
• Sorin Group
• InspireMD Inc.
• C. R. Bard Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 冠動脈ステント市場2029：新たな機会を提供する国
• 冠動脈ステント市場2029：新たな機会を提供するセグメント
• 冠動脈ステント市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Coronary stents are small, expandable tubes used to open narrowed or blocked coronary arteries, which supply blood to the heart muscle. Typically constructed from metal mesh, these devices are inserted during a procedure known as percutaneous coronary intervention (PCI) or angioplasty. The stent is delivered via a balloon catheter and expanded at the blockage site to restore proper blood flow.

The main types of coronary stents include dual therapy stents, radioactive stents, thrombectomy stents, covered stents, bioresorbable stents, biodegradable stents, hybrid stents, drug-eluting stents, and bare metal stents. Dual therapy stents integrate drug-eluting and bioresorbable technologies to offer both medication release and gradual absorption of the stent structure. Various technologies used in their manufacture include laser cutting, 3D printing, microfabrication, nanotechnology, and electropolishing. Materials used in stent production can include cobalt-chromium, stainless steel, platinum-chromium, and nickel-titanium. Stents can be self-expandable or balloon-expandable and are utilized by hospitals, ambulatory surgical centers, specialty clinics, and other healthcare facilities.

The coronary stents market research report is one of a series of new reports from The Business Research Company that provides coronary stents market statistics, including coronary stents industry global market size, regional shares, competitors with a coronary stents market share, detailed coronary stents market segments, market trends and opportunities, and any further data you may need to thrive in the coronary stents industry. This coronary stents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The coronary stents market size has grown strongly in recent years. It will grow from $11.06 billion in 2024 to $12.02 billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to growing preference for minimally invasive procedures, expansion of healthcare access in emerging markets, rising healthcare expenditure, increase in percutaneous coronary interventions, growing number of cardiologists.

The coronary stents market size is expected to see strong growth in the next few years. It will grow to $16.5 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to increasing incidence of cardiovascular diseases, aging population, rising awareness about cardiovascular health, supportive government programs and funding, growing incidence of lifestyle diseases. Major trends in the forecast period include innovations in stent technology, innovations in imaging technologies, strategic collaborations and partnerships, innovations in stent materials, technological integration with digital health.

The growing prevalence of cardiovascular diseases (CVDs) is anticipated to drive the expansion of the coronary stent market. CVDs encompass a range of heart and blood vessel disorders, including coronary artery disease, heart failure, stroke, and hypertension. The rise in cardiovascular diseases is attributed to factors such as an aging population, increased rates of risk factors such as obesity, diabetes, sedentary lifestyles, poor diet, and stress. Coronary stents are crucial in treating CVDs as they help open narrowed or blocked coronary arteries, improving blood flow to the heart and reducing the risk of heart attacks. For example, a report from the American College of Cardiology in August 2022 projected significant increases in cardiovascular risk factors in the U.S. from 2025 to 2060. It predicted a 39.3% increase in diabetes cases to 55 million, a 27.6% rise in dyslipidemia to 126 million, a 25.1% increase in hypertension to 162 million, and an 18.3% rise in obesity to 126 million. The most notable increases are expected in stroke (33.8% rise to 15 million) and heart failure (33.4% rise to 13 million), with ischemic heart disease and heart attacks also showing substantial growth. This rising prevalence of CVDs is driving the demand for coronary stents.

Companies in the coronary stent market are focusing on developing advanced products such as drug-eluting stents to minimize the need for repeat procedures compared to traditional bare-metal stents. Drug-eluting stents are specialized devices coated with medication that gradually releases drugs to prevent the re-narrowing of arteries. For instance, in May 2024, Abbott, a US-based healthcare company, introduced the XIENCE Sierra Everolimus Eluting Coronary Stent System in India. This stent features an enhanced design, a new delivery system, and unique size options tailored for complex cases. It maintains a specialized coating to reduce the risk of artery re-blockage, consistent with other XIENCE stents, and boasts a strong safety record supported by over 120 clinical trials involving more than 120,000 patients.

In October 2022, Cordis, a US-based developer of cardiovascular and endovascular devices, acquired MedAlliance for an undisclosed amount. This acquisition will enable Cordis to reach two million patients globally by 2027 with the SELUTION SLR (Sustained Limus Release) drug-eluting balloon. Cordis will also co-promote MedAlliance's SELUTION SLR drug-eluting balloon in existing markets. MedAlliance is a Switzerland-based manufacturer of coronary stents.

Major companies operating in the coronary stents market are Abbott Laboratories, Medtronic Plc, Biosensors International Group Ltd., Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, W. L. Gore & Associates Inc., Cook Medical Inc., BIOTRONIK SE & Co. KG, Lepu Medical Technology (Beijing) Co. Ltd., Meril Life Sciences Pvt. Ltd, MicroPort Scientific Corporation, OrbusNeich, Asahi Intecc Co. Ltd., Sahajanand Medical Technologies Limited, Translumina GmbH, Stentys S.A., Sorin Group, InspireMD Inc., C. R. Bard Inc., AMG International GmbH, Svelte Medical Systems Inc., Zorion Medical Inc., Spectranetics Corporation

North America was the largest region in the coronary stents market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the coronary stents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the coronary stents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The coronary stent market consists of revenues earned by entities by providing services such as product training and education, technical support, clinical support, research and development, customized solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The coronary stent market also includes sales of covered stents, balloon catheters, guidewires, embolic protection devices and imaging systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Coronary Stents Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on coronary stents market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for coronary stents ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The coronary stents market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Dual Therapy Stents; Radioactive Stents; Thrombectomy Stents; Covered Stents; Bioresorbable Stents; Biodegradable Stents; Hybrid Stents; Drug-Eluting Stents; Bare Metal Stents
• 2) By Technology: Laser Cutting; 3D-Printed Stents; Microfabrication; Nanotechnology-Based Stents; Electropolishing; Others Technologies
• 3) By Raw Material: Cobalt-Chromium; Stainless Steel; Platinum-Chromium; Nickel-Titanium; Polymer
• 4) By Deployment: Self-Expandable Stents; Balloon-Expandable Stents
• 5) By End Uses: Hospitals And Ambulatory Surgical Centers; Specialty Clinics; Other End Uses
• Subsegments:
• 1) By Dual Therapy Stents: Sirolimus-Eluting Dual Therapy Stents; Paclitaxel-Eluting Dual Therapy Stents; Everolimus-Eluting Dual Therapy Stents
• 2) By Radioactive Stents: Beta Radiation Stents; Gamma Radiation Stents; Other Radiation Stents
• 3) By Thrombectomy Stents: Manual Thrombectomy Stents; Mechanical Thrombectomy Stents; Hydrodynamic Thrombectomy Stents
• 4) By Covered Stents: PTFE-Covered Stents; ePTFE-Covered Stents; Polyurethane-Covered Stents; Other Covered Stents
• 5) By Bioresorbable Stents: Polymer-Based Bioresorbable Stents; Metal-Based Bioresorbable Stents; Ceramic-Based Bioresorbable Stents
• 6) By Biodegradable Stents: Polymeric Biodegradable Stents; Magnesium-Based Biodegradable Stents; Other Biodegradable Stents
• 7) By Hybrid Stents: Hybrid Drug-Eluting Stents; Hybrid Biodegradable Or Metal Stents; Other Hybrid Stents
• 8) By Drug-Eluting Stents: Sirolimus-Eluting Stents; Paclitaxel-Eluting Stents; Everolimus-Eluting Stents; Zotarolimus-Eluting Stents; Other Drug-Eluting Stents
• 9) By Bare Metal Stents: Stainless Steel Bare Metal Stents; Cobalt Chromium Bare Metal Stents; Other Bare Metal Stents
• Companies Mentioned: Abbott Laboratories; Medtronic Plc; Biosensors International Group Ltd.; Boston Scientific Corporation; B. Braun Melsungen AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Coronary Stents Market Characteristics

3. Coronary Stents Market Trends And Strategies

4. Coronary Stents Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Coronary Stents Growth Analysis And Strategic Analysis Framework

• 5.1. Global Coronary Stents PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Coronary Stents Market Growth Rate Analysis
• 5.4. Global Coronary Stents Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Coronary Stents Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Coronary Stents Total Addressable Market (TAM)

6. Coronary Stents Market Segmentation

• 6.1. Global Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dual Therapy Stents
• Radioactive Stents
• Thrombectomy Stents
• Covered Stents
• Bioresorbable Stents
• Biodegradable Stents
• Hybrid Stents
• Drug-Eluting Stents
• Bare Metal Stents
• 6.2. Global Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Laser Cutting
• 3D-Printed Stents
• Microfabrication
• Nanotechnology-Based Stents
• Electropolishing
• Others Technologies
• 6.3. Global Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cobalt-Chromium
• Stainless Steel
• Platinum-Chromium
• Nickel-Titanium
• Polymer
• 6.4. Global Coronary Stents Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Self-Expandable Stents
• Balloon-Expandable Stents
• 6.5. Global Coronary Stents Market, Segmentation By End Uses, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Ambulatory Surgical Centers
• Specialty Clinics
• Other End Uses
• 6.6. Global Coronary Stents Market, Sub-Segmentation Of Dual Therapy Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sirolimus-Eluting Dual Therapy Stents
• Paclitaxel-Eluting Dual Therapy Stents
• Everolimus-Eluting Dual Therapy Stents
• 6.7. Global Coronary Stents Market, Sub-Segmentation Of Radioactive Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Beta Radiation Stents
• Gamma Radiation Stents
• Other Radiation Stents
• 6.8. Global Coronary Stents Market, Sub-Segmentation Of Thrombectomy Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Manual Thrombectomy Stents
• Mechanical Thrombectomy Stents
• Hydrodynamic Thrombectomy Stents
• 6.9. Global Coronary Stents Market, Sub-Segmentation Of Covered Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• PTFE-Covered Stents
• ePTFE-Covered Stents
• Polyurethane-Covered Stents
• Other Covered Stents
• 6.10. Global Coronary Stents Market, Sub-Segmentation Of Bioresorbable Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polymer-Based Bioresorbable Stents
• Metal-Based Bioresorbable Stents
• Ceramic-Based Bioresorbable Stents
• 6.11. Global Coronary Stents Market, Sub-Segmentation Of Biodegradable Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polymeric Biodegradable Stents
• Magnesium-Based Biodegradable Stents
• Other Biodegradable Stents
• 6.12. Global Coronary Stents Market, Sub-Segmentation Of Hybrid Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hybrid Drug-Eluting Stents
• Hybrid Biodegradable Or Metal Stents
• Other Hybrid Stents
• 6.13. Global Coronary Stents Market, Sub-Segmentation Of Drug-Eluting Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sirolimus-Eluting Stents
• Paclitaxel-Eluting Stents
• Everolimus-Eluting Stents
• Zotarolimus-Eluting Stents
• Other Drug-Eluting Stents
• 6.14. Global Coronary Stents Market, Sub-Segmentation Of Bare Metal Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Stainless Steel Bare Metal Stents
• Cobalt Chromium Bare Metal Stents
• Other Bare Metal Stents

7. Coronary Stents Market Regional And Country Analysis

• 7.1. Global Coronary Stents Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Coronary Stents Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Coronary Stents Market

• 8.1. Asia-Pacific Coronary Stents Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Coronary Stents Market

• 9.1. China Coronary Stents Market Overview
• 9.2. China Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Coronary Stents Market

• 10.1. India Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Coronary Stents Market

• 11.1. Japan Coronary Stents Market Overview
• 11.2. Japan Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Coronary Stents Market

• 12.1. Australia Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Coronary Stents Market

• 13.1. Indonesia Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Coronary Stents Market

• 14.1. South Korea Coronary Stents Market Overview
• 14.2. South Korea Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Coronary Stents Market

• 15.1. Western Europe Coronary Stents Market Overview
• 15.2. Western Europe Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Coronary Stents Market

• 16.1. UK Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Coronary Stents Market

• 17.1. Germany Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Coronary Stents Market

• 18.1. France Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Coronary Stents Market

• 19.1. Italy Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Coronary Stents Market

• 20.1. Spain Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Coronary Stents Market

• 21.1. Eastern Europe Coronary Stents Market Overview
• 21.2. Eastern Europe Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Coronary Stents Market

• 22.1. Russia Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Coronary Stents Market

• 23.1. North America Coronary Stents Market Overview
• 23.2. North America Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Coronary Stents Market

• 24.1. USA Coronary Stents Market Overview
• 24.2. USA Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Coronary Stents Market

• 25.1. Canada Coronary Stents Market Overview
• 25.2. Canada Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Coronary Stents Market

• 26.1. South America Coronary Stents Market Overview
• 26.2. South America Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Coronary Stents Market

• 27.1. Brazil Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Coronary Stents Market

• 28.1. Middle East Coronary Stents Market Overview
• 28.2. Middle East Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Coronary Stents Market

• 29.1. Africa Coronary Stents Market Overview
• 29.2. Africa Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Coronary Stents Market Competitive Landscape And Company Profiles

• 30.1. Coronary Stents Market Competitive Landscape
• 30.2. Coronary Stents Market Company Profiles
  • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Biosensors International Group Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis

31. Coronary Stents Market Other Major And Innovative Companies

• 31.1. Terumo Corporation
• 31.2. W. L. Gore & Associates Inc.
• 31.3. Cook Medical Inc.
• 31.4. BIOTRONIK SE & Co. KG
• 31.5. Lepu Medical Technology (Beijing) Co. Ltd.
• 31.6. Meril Life Sciences Pvt. Ltd.
• 31.7. MicroPort Scientific Corporation
• 31.8. OrbusNeich
• 31.9. Asahi Intecc Co. Ltd.
• 31.10. Sahajanand Medical Technologies Limited
• 31.11. Translumina GmbH
• 31.12. Stentys S.A.
• 31.13. Sorin Group
• 31.14. InspireMD Inc.
• 31.15. C. R. Bard Inc.

32. Global Coronary Stents Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Coronary Stents Market

34. Recent Developments In The Coronary Stents Market

35. Coronary Stents Market High Potential Countries, Segments and Strategies

• 35.1 Coronary Stents Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Coronary Stents Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Coronary Stents Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer